ArticlePharmaceutics2024

Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective.

Agnija Kivrane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.